Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Bioterrorism & Biodefense received 1129 citations as per Google Scholar report
Gene G. Olinger works in Virology Division, Viral Therapeutics Department, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, 21702, USA |
Assessment of High-Throughput Screening (HTS) Methods for High-Consequence Pathogens
Currently, there are no Food and Drug Administration (FDA)-approved antiviral drugs or therapeutics for many of the biosafety level three (BSL-3) and four (BSL-4) pathogens. Many of these high-consequence pathogens, including Venezuelan equine encephalitis virus (VEEV), Ebola virus (EBOV), Marburg virus (MARV), and Lassa virus (LASV), are classifie... Read More»
Brian M. Friedrich, Corinne E. Scully, Jennifer M. Brannan, Monica M. Ogg, Sara C. Johnston, Lisa E. Hensley, Gene G. Olinger and Darci R. Smith
Review Article: J Bioterror Biodef 2011, S3:005
Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals